Debora M. Meijer
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Accurate Prediction of Central Conventional Chondrosarcoma Risk and Outcome Using Methylation Profiling: CHROME.
Journal: Genes, chromosomes & cancer
Published: May 29, 2026
Methylome Profiling of Cartilage Tumors: A Promising New Diagnostic Tool?
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: March 09, 2026
An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central Chondrosarcoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 25, 2025
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
Journal: Cancer immunology, immunotherapy : CII
Published: March 27, 2025
Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases.
Journal: BMJ oncology
Published: May 22, 2024
The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis.
Journal: Genes, chromosomes & cancer
Published: May 14, 2024
Multimodal profiling of chordoma immunity reveals distinct immune contextures.
Journal: Journal for immunotherapy of cancer
Published: January 02, 2024
Using picoliter droplet deposition to track clonal competition in adherent and organoid cancer cell cultures.
Journal: Scientific reports
Published: February 12, 2023
A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor.
Journal: Genes, chromosomes & cancer
Published: August 31, 2022
Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?
Journal: Biomedicines
Published: July 21, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026